IMC Chicago’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

IMC Chicago’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$483K	Buy	+71,573	New	+$1.96M	﹤0.01%	4075

Other funds holding CRCD

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

IMC Chicago's CRCD Position: Q1 2026 in Review

IMC Chicago opened a new position in T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q1 2026: 71,573 shares worth $483K. The stake represents ﹤0.01% of the portfolio and ranks #4075 among its holdings.

8 funds tracked by Wall St. Rank hold CRCD as of Q1 2026.

IMC Chicago held 71,573 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $483K as of Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF was a new IMC Chicago position in Q1 2026.
T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4075 holding.
8 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.